Tradestie Institutional Equity Comparison Engine
HH vs AMS โ Head-to-Head Terminal
6-dimension institutional benchmarking across valuation, multi-year operating margins, normalized momentum, and dealer gamma corridors.
Pillar 1 Executive Scorecard & Category Winner Tally
AMS Overall Edge
AMS Captures Institutional Edge (2โ1 Pillars ยท 7โ3 Matrix Metrics)
Tradestie Institutional Equity Comparison Engine assigns the overall head-to-head edge to American Shared Hospital Services (AMS) driven by superior Valuation, Growth & Margin while HH counters with relative strength in Momentum & Technical. Fundamentally, HH trades at N/M Forward P/E with N/A operating margin (N/A YoY revenue) versus AMS at 44.6x Forward P/E and -7.4% operating margin (+19.2% YoY). In options structure, HH sits in UNCLASSIFIED (N/A IV; Dealer Gamma Walls on Pro) against AMS sits in UNCLASSIFIED (N/A IV; Dealer Gamma Walls on Pro).
Valuation Winner
AMS
HH N/M vs AMS 44.6x Fwd P/E
Growth & Margin Winner
AMS
Op Margin N/A vs -7.4% ยท YoY N/A vs +19.2%
Momentum & Technical Winner
HH
1Y -0.1% vs -52.2% ยท 52W Pos 45% vs 6%
Options & Structure Winner
Tie
UNCLASSIFIED (N/A IV) vs UNCLASSIFIED (N/A IV)
HH
US Equity
HH
Institutional Equity
$24.97
-0.1% 1D
Market Cap
N/A
1M Return
-0.1%
1Y Return
-0.1%
Forward P/E
N/M
Unified AI Score
54.7 / 100
HOLD
Tech 50.0
Fund 50.0
Flow 50.0
Mom 50.0
AMS
NYSE American
American Shared Hospital Services
Services-Medical Laboratories
$1.07
-0.93% 1D
Market Cap
$7.2M
1M Return
-16.41%
1Y Return
-52.23%
Forward P/E
44.6x
Unified AI Score
33.8 / 100
SELL
Tech 24.0
Fund 38.0
Flow 50.0
Mom 30.0
Pillar 2 Normalized Relative Return Performance (% Indexed to 0%)
1Y Indexed Return:
HH -0.1%
AMS -52.23%
Spread: +16.31 pp (HH Lead)
Pillar 3 Operating Profitability Benchmark (Trailing 12-Month)
HH TTM Op. Margin: N/A
AMS TTM Op. Margin: -7.4%
Standardized multi-year USD domestic revenue schedules are unavailable for foreign-domiciled ADR filing schedules on HH vs AMS. Trailing 12-month operating profitability (HH N/A vs AMS -7.4%) and valuation multiples (HH N/M vs AMS 44.6x Forward P/E) are benchmarked directly in Pillar 4 below.
Pillar 4 Head-to-Head Fundamental & Valuation Matrix
| Institutional Metric | HH | AMS | Criterion | Row Winner |
|---|---|---|---|---|
| Market Capitalization Scale | N/A | $7.2M | Larger Scale | AMS |
| Trailing P/E Ratio Valuation | N/M | 44.6x | Lower Multiple | AMS |
| Forward P/E Ratio Valuation | N/M | 44.6x | Lower Multiple | AMS |
| Revenue Growth (YoY) Growth | N/A | +19.2% | Higher Growth | AMS |
| Operating Margin (TTM) Profitability | N/A | -7.4% | Higher Margin | AMS |
| Net Profit Margin Profitability | N/A | -5.8% | Higher Margin | AMS |
| Return on Equity (ROE) Capital Efficiency | N/A | -12.1% | Higher ROE | AMS |
| 52-Week Range Position Momentum | 45% ($25โ$25) | 6% ($1โ$2) | Stronger Trend | HH |
| Beta / 30D Volatility Risk Regime | N/A | 0.18ฮฒ ยท 46% Vol | Lower Realized Risk | HH |
| Unified Institutional Score Composite Signal | 54.7 / 100 (HOLD) | 33.8 / 100 (SELL) | Higher Composite | HH |
Pillar 5 Options Structure, IV Regime & Dealer Gamma Corridor
Full HH vs AMS Buy Guide
HH
UNCLASSIFIED
0d in phase ยท OBV NEUTRAL
Put Wall Floor
Pro Only
Call Wall Magnet
Pro Only
IV Percentile
N/A
IV Regime
Unclassified
AMS
UNCLASSIFIED
0d in phase ยท OBV NEUTRAL
Put Wall Floor
Pro Only
Call Wall Magnet
Pro Only
IV Percentile
N/A
IV Regime
Unclassified
Pillar 6 90-Day Technical & R&D Innovation Disclosures
Corporate R&D & Foundry Tracker
Neither HH nor AMS registered frontier semiconductor/AI engineering publications in the trailing 90-day window; head-to-head edge is anchored on operating margin trajectory, valuation multiples, and options structure above.